甘露醇是雪卡毒素鱼类中毒的首选治疗吗?
本文为叙述性综述,检索1966年至2017年3月31日文献,最终纳入53篇临床文章及9篇其他药物治疗报告,评估甘露醇及其他药物治疗雪卡毒素鱼类中毒的证据。支持甘露醇的证据包括4项非对照病例系列、1项前瞻性非盲比较试验及若干病例报告;反对证据为1项样本量小、存在若干潜在局限的随机对照试验,该试验显示甘露醇与生理盐水无显著差异。其他药物(阿米替林、氟西汀、度洛西汀、加巴喷丁、普瑞巴林或托卡尼)仅有10篇病例报告和3项部分重叠的病例系列,均需长期治疗维持症状改善,且均未显示优于甘露醇。作者结论认为急性病例可考虑静脉甘露醇,持续性病例的神经病变药物似乎可抑制感觉异常,但所有治疗的人类证据质量均低。
要点
- 作者认为急性雪卡毒素鱼类中毒可考虑使用静脉甘露醇(基于4项非对照病例系列、1项前瞻性非盲比较试验及若干病例报告)。
- 1项样本量小、存在若干潜在局限的随机对照试验显示甘露醇与生理盐水无显著差异,是反对使用甘露醇的主要证据。
- 其他药物(阿米替林、氟西汀、度洛西汀、加巴喷丁、普瑞巴林或托卡尼)仅见于10篇病例报告和3项部分重叠的病例系列,均需长期治疗维持症状改善。
- 上述其他药物均未显示优于甘露醇;所有治疗的人类证据质量均低。
- 典型感觉异常为冷性触物感痛,更准确的描述是接触寒冷时出现烧灼痛,而非简单的冷热感觉倒错。
适用人群与场景
- 食用热带和亚热带水域捕获的肉食性礁鱼(如石斑鱼、梭子鱼、隆头鱼、琥珀鱼、王鱼和鳗鱼)后发生雪卡毒素鱼类中毒的患者。
- 纳入文献涵盖急性期及持续性神经症状病例;排除6篇未清楚描述雪卡毒素中毒或缺乏治疗或结局信息的临床报告(2项病例系列和4篇病例报告)。
诊断标准与关键阈值
- 雪卡毒素鱼类中毒的特征:摄入后最初1至2天出现早期恶心、呕吐和腹泻,随后出现感觉障碍。
- 经典感觉异常为冷性触物感痛,常被描述为冷热感觉倒错,但更准确的描述是接触寒冷时出现烧灼痛。
处置流程与药物剂量
- 作者认为急性雪卡毒素鱼类中毒病例可考虑使用静脉甘露醇。
- 其他神经病变综合征所用药物(阿米替林、氟西汀、度洛西汀、加巴喷丁、普瑞巴林或托卡尼)似乎可抑制持续性雪卡毒素中毒病例的感觉异常,每种药物均需长期治疗以维持症状改善;均未显示优于甘露醇。
研究设计与关键结果
- 本文为叙述性综述,检索PubMed和Embase 1966年至2017年3月31日文献,初检识别85篇文章,其中36篇与综述问题相关;二次检索补充23篇参考文献;排除6篇临床报告后,53篇临床文章纳入综述。
- 另以「ciguatera」AND「treatment」NOT「mannitol」检索PubMed识别128篇文章,其中9篇描述了特定药物治疗及其结局。
- 支持甘露醇的证据包括4项非对照病例系列、1项前瞻性非盲比较试验及若干病例报告;反对证据为1项随机对照试验,该试验样本量小且存在若干潜在局限。
- 2002年一项小型随机对照试验报告甘露醇与生理盐水之间无显著差异。
- 体外分离神经元实验显示雪卡毒素引起神经元水肿、开放某些钠通道、阻断钾通道、刺激后产生不受控的重复动作电位,加入甘露醇可减轻水肿并减少无指令动作电位;但大鼠腹腔注射雪卡毒素增加神经元不应期并减慢神经传导速度,甘露醇治疗未能纠正这些效应。
- 其他药物治疗证据仅包括10篇病例报告和3项部分重叠的病例系列,描述使用阿米替林、氟西汀、度洛西汀、加巴喷丁、普瑞巴林或托卡尼,每种药物均需长期治疗以维持症状改善,且均未显示优于甘露醇。
证据类型、等级与局限
- 证据类型:叙述性综述(共识性证据回顾),汇总支持与反对甘露醇及其他药物治疗雪卡毒素鱼类中毒的证据。
- 作者结论指出所有治疗的人类证据质量均低。
- 支持甘露醇的证据包括4项非对照病例系列、1项前瞻性非盲比较试验和若干病例报告;反对甘露醇的证据为1项随机对照试验,该试验样本量小且存在若干潜在局限。
- 其他药物治疗的证据仅来自10篇病例报告和3项部分重叠的病例系列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为急性雪卡毒素鱼类中毒病例可考虑使用静脉甘露醇。
- 对于持续性雪卡毒素中毒病例的感觉异常,其他神经病变综合征所用药物(阿米替林、氟西汀、度洛西汀、加巴喷丁、普瑞巴林或托卡尼)似乎可抑制症状,但需长期治疗维持改善,且均未显示优于甘露醇。
- 作者指出所有治疗的人类证据质量均低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Ciguatera fish poisoning arises primarily from consumption of carnivorous reef fish caught in tropical and sub-tropical waters. Ciguatoxins, a class of tasteless, heat-stable, polycyclic toxins produced by dinoflagellates, accumulate through the food chain and concentrate in various carnivorous fish, such as groupers, barracudas, wrasses, amberjack, kingfishes, and eels. Characteristics of ciguatera fish poisoning include early nausea, vomiting, and diarrhea in the first one to two days post ingestion, followed by the appearance of sensory disturbances. The classic dysaesthesia is cold allodynia, often described as reversal of hot and cold sensation, but a more accurate description is burning pain on exposure to cold.
OBJECTIVE: To discuss and appraise the evidence regarding the use of mannitol or other drugs in treating ciguatera framed in the historical context of the last four decades.
METHODS: We searched PubMed and Embase for all years from 1966 to March 31, 2017 with search terms "ciguatera", "mannitol", and "treatment". These searches identified 85 articles, of which 36 were relevant to the review question. We searched Google Scholar to supplement the primary search and reviewed the references of articles for sources overlooked in the original searches. These secondary searches identified another 23 references. We excluded six clinical reports (two case series and four case reports) which did not clearly describe ciguatera or which lacked information on treatment or outcome. Fifty-three clinical articles remained for review. We searched PubMed using "ciguatera" AND "treatment" NOT "mannitol" to better identify reports describing other treatments. The search identified 128 articles, of which nine described specific pharmacological treatments and their outcomes. We combined our findings into a consensus review of the evidence both for and against the use of mannitol or other medications for ciguatera fish poisoning. Early human evidence of effectiveness of mannitol: A 1988 report described an unexpected discovery that intravenous mannitol could rapidly and effectively treat ciguatera fish poisoning. Several other uncontrolled case series and case reports appeared to support the use of mannitol. In 2002, a small randomized, controlled trial reported no significant difference between mannitol and normal saline. Subsequent case reports have cited this study as the reason for or to withhold mannitol. Thus, some controversy exists regarding whether mannitol is useful or not for treating ciguatera fish poisoning. Basic science and animal research on ciguatera and mannitol: In vitro experiments of isolated neurons demonstrate that ciguatoxins produce neuronal edema, open certain sodium channels, block potassium channels, cause uncontrolled and repetitive action potentials after a stimulus. Addition of mannitol decreases the edema and reduces the uncommanded action potentials. However, intraperitoneal injection of ciguatoxin in rats increases neuronal refractory period and slows nerve conduction velocity. Treatment with mannitol fails to correct these effects. Comparative trials of mannitol: Evidence supporting mannitol for ciguatera fish poisoning includes four uncontrolled case series, one prospective, unblinded comparative trial and several case reports. Evidence against mannitol consists of one RCT, which has a small sample size and several potential limitations. Empirical human experience with other treatments: Evidence regarding other treatments consists only of ten case reports and three overlapping case series that describe using amitriptyline, fluoxetine, duloxetine, gabapentin, pregabalin, or tocainide. For each of these, a long duration of treatment appears to be necessary to maintain symptomatic improvement. None of these treatments has been shown to be superior to mannitol.
CONCLUSIONS: It is reasonable to consider using intravenous mannitol in cases of acute ciguatera fish poisoning. Medications used in other neuropathic syndromes appear to suppress the paresthesiae of persistent ciguatera cases. However, the human evidence is of low quality for all treatments.
参考来源
- Mullins ME, Hoffman RS. Is mannitol the treatment of choice for patients with ciguatera fish poisoning? Clin Toxicol (Phila). 2017. PMID: 28535116. doi:10.1080/15563650.2017.1327664
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。